TScan Therapeutics appoints Leiden Dworak as Principal Accounting Officer

TScan Therapeutics, Inc.

Appointment effective August 14, 2025; Dworak also serves as VP Finance since April 2022.
Jason Amello ceases as Principal Accounting Officer but remains CFO and Principal Financial Officer.
Dworak previously held the same PAO role from July 2023 to January 2024.
17 years biotech finance experience including VP Finance at AVROBIO and Director at Moderna.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.